April 21, 2014

Your Private Medical Records Are Being Sold to Drug Companies

Medical Your Private Medical Records Are Being Sold to Drug Companies

by Alliance for Natural Health

Even worse, half of all US states leave enough information in the records that YOU can be clearly identified. Action Alert!

Hospitals and other medical organizations are supposed to be bound by HIPAA (the Health Insurance Portability and Accountability Act) to keep medical records private. Patient information that is shared is supposed to be stripped of key identifying information (this is known as the Safe Harbor rule). However, HIPAA and other privacy legislation is riddled with loopholes—so many that it has been estimated that over 800,000 organizations can access your records.

Here is one big, fat loophole: state public health agencies are exempt from Safe Harbor rules when they sell private medical records as part of a health database. When this medical data is cross-referenced with other public information (such as news reports and other databases), it can reveal your identity.

Many states in the US voluntarily follow HIPAA guidelines when sharing electronic medical records, but at least twenty-five states leave some combination of identifying information that makes it possible for whoever buys the data to pinpoint anyone’s personal medical record—and then make it public. Records in Washington, New York, New Jersey, Tennessee, and Arizona were particularly vulnerable, according to records reviewed by Bloomberg News and Latanya Sweeney, director of Harvard University’s Data Privacy Lab.

Who would want this data? The drug industry, for one. Pharmaceutical companies are major buyers of these medical records—they use them to design ads to doctors and target potential patients. Other buyers include IMS Health, a provider of prescription data, also used by drug companies; OptumInsight, a division of UnitedHealth Group, the country’s biggest health insurer; and WebMD, which uses the data to tailor information found on their website.

As the public becomes more aware of just how vulnerable electronic medical records (EMRs) are, consumers may be more reluctant to seek medical care. Patients rely on doctor–patient confidentiality, and that sacred trust is meaningless if one’s information is sold to the highest bidder.

Case in point: there is a new form of gonorrhea that is resistant to cephalosporin and other antibiotics. This is a serious public health concern, and one that requires careful treatment (not to mention a great deal more research). While young people are at the highest risk for gonorrhea, they are also the most likely to hesitate to see a doctor—particularly for such a personal, potentially humiliating issue—if they fear their private information will be exposed.

In addition, EMRs can cost taxpayers money. The digital nature of the data means it is much easier for doctors to overbill, whether by mistake or through fraud. As we reported in February, doctors can claim to provide more services than they actually do; they can also cut and paste the same examination findings for multiple patients for the sake of expediency, even if those same findings only applied to one or two. EMRs can actually increase the paperwork burden, are subject to serious technological glitches, and of course are tremendously vulnerable to hackers and other security violations.

In an interesting new trend, many doctors are choosing to operate outside the system all together, providing “concierge” medical services to patients on a prepaid membership-fee basis rather than on a standard insurance model. Some concierge doctors stop accepting insurance altogether and can charge as little as $38 a month, though for most people the annual fee amounts to roughly $4 to $5 per day. This system can be a win/win for doctors and patients: patients’ medical records can more easily be kept outside of the huge medical record databases; it can cut down on unnecessary treatments and, of course, high insurance costs; and it allows doctors to see fewer patients and give the ones they have more personalized care.

Most of the medical industry, however, is still stuck in this miasma of messed up medical records, poor security, and legal loopholes that allow patients’ private information to be publicly exposed.

Action Alert! Ask Congress to amend HIPAA to allow patients to opt out—to keep their medical information from being sold or shared with any entity that is not currently giving the patient medical treatment.

Take Action11 Your Private Medical Records Are Being Sold to Drug Companies

Read the full article here: http://www.anh-usa.org/your-private-medical-records-are-being-sold-to-drug-companies


0 commentsback to post

Other articlesgo to homepage

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

Congressman Bill Posey’s strong resolve and demands for transparency were evident as he discussed the Center for Disease Control (CDC)’s handling of vaccine safety studies which affect “our most precious resource in our nation – our children.” The 30-minute interview, conducted by vaccine industry watchdog, PhD biochemist Brian Hooker, delves into what Posey called “the incestuous relationship between the public health community and the vaccine makers and public officials.”

The Florida legislator, known as “Mr. Accountabililty,” did not mince words when criticizing current and past CDC officials including indicted fraudster Dr. Poul Thorsen; CDC director turned Merck Vaccine President Dr. Julie Gerberding; and the agency’s current spokesperson regarding autism and vaccines, Dr. Coleen Boyle.

Congressman Posey said, “The CDC can’t be trusted regarding investigating vaccine safety. Huge conflict of interest. I think the CDC should be investigated.”

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

In an interview with Dr. Bernard Dalbergue, a former pharmaceutical industry physician with Gardasil manufacturer Merck, he predicts that Gardasil will become the greatest medical scandal of all time. Dr. Dalbergue believes that at some point in time, the evidence will add up to prove that this vaccine, technical and scientific feat that it may be, has absolutely no effect on cervical cancer and that all the very many adverse effects which destroy lives and even kill young girls, serves no other purpose than to generate profit for the manufacturers.

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

An important new book by a recognized medical research expert describes Big Pharma as akin to the Mafia. In an interview conducted by our colleagues at ANH-Europe, Dr. Peter C. Gøtzsche exposes the flaws of the drug approval system, our reliance on dangerous drugs, and the deadly co-dependence between regulators and industry. Dr. Gøtzsche is co-founder of the highly respected Cochrane Collaboration and Cochrane Reviews, a leading journal of evidence-based medicine. The interview is particularly timely now that the FDA has decided to remove restrictions on the dangerous drug Avandia.

Dr. Gøtzsche’s new book, Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare, points out that the pharmaceutical industry is allowed to test their own drugs, and thus effectively be their own judge. He calls this a threat to safe medicine and asks for open access to all research data, including raw data, because otherwise, data can be easily suppressed and conclusions manipulated by industry.

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical marijuana, or cannabis, is legal in 20 US states, where it is used for a variety of medical conditions such as mood disorders, pain disorders, multiple sclerosis, and even cancer. Parents of children with epilepsy met at a news conference to share their dismay that Governor Mark Dayton refuses to legalize medical marijuana. About 85 percent to 95 percent of Americans are in favor of medical cannabis, and nearly 60 percent are in favor of legalizing marijuana. Cannabis shows outstanding promise as a medicinal plant, largely due to its cannabidiol (CBD) content. Cannabinoids interact with your body by way of naturally occurring cannabinoid receptors embedded in cell membranes throughout your body.

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Pharmaceutical company payments to doctors extend far beyond rank-and-file clinicians — and deep into the leadership of America’s teaching hospitals, according to a study published recently in the Journal of the American Medical Association.

A team of researchers at the University of Pittsburgh Medical Center examined the boards of the 50 largest drug companies by global sales (excluding three companies that were not publicly traded). The researchers found that 40 percent — 19 companies — had at least one board member who also held a leadership role at an academic medical center. Sixteen of the 17 companies based in the United States had at least one. Several had more than one. All told, the research team found that 41 of the companies’ 2012 board members held leadership positions at academic medical centers. Six of the 41 were pharmaceutical company executives who served on hospital boards of directors or held other leadership posts.

The authors wrote that when academic medical leaders serve on pharmaceutical company boards, it can lead to conflicts not only for individuals, but for the critically important health care institutions they guide.

read more


Get the news right in your inbox!